These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35164657)

  • 21. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
    Trasino SE; Tang XH; Jessurun J; Gudas LJ
    J Mol Med (Berl); 2016 Oct; 94(10):1143-1151. PubMed ID: 27271256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
    Leung C; Herath CB; Jia Z; Andrikopoulos S; Brown BE; Davies MJ; Rivera LR; Furness JB; Forbes JM; Angus PW
    World J Gastroenterol; 2016 Sep; 22(35):8026-40. PubMed ID: 27672297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products.
    Fernando DH; Forbes JM; Angus PW; Herath CB
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.
    Chandrashekaran V; Seth RK; Dattaroy D; Alhasson F; Ziolenka J; Carson J; Berger FG; Kalyanaraman B; Diehl AM; Chatterjee S
    Redox Biol; 2017 Oct; 13():8-19. PubMed ID: 28551086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice.
    Moe KT; Yin NO; Naylynn TM; Khairunnisa K; Wutyi MA; Gu Y; Atan MS; Wong MC; Koh TH; Wong P
    J Cell Mol Med; 2011 Dec; 15(12):2601-13. PubMed ID: 21251215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model.
    Allam MM; El Gazzar WB
    Arch Physiol Biochem; 2018 Feb; 124(1):10-17. PubMed ID: 28696785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH/NADP
    Mejía SÁ; Gutman LAB; Camarillo CO; Navarro RM; Becerra MCS; Santana LD; Cruz M; Pérez EH; Flores MD
    Eur J Pharmacol; 2018 Jan; 818():499-507. PubMed ID: 29069580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of RAGE prevents chronic intermittent hypoxia-induced nonalcoholic fatty liver disease via blockade of NF-кB pathway.
    Tan H; Hu J; Zuo W; Huang Y; Cui J; Gong F; Bai W
    Gene Ther; 2023 Apr; 30(3-4):278-287. PubMed ID: 35821256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of catalpol on diabetes mellitus-induced male reproductive damage via suppression of the AGEs/RAGE/Nox4 signaling pathway.
    Jiao N; Chen Y; Zhu Y; Wang W; Liu M; Ding W; Lv G; Lu J; Yu B; Xu H
    Life Sci; 2020 Sep; 256():116736. PubMed ID: 31398417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of nicotinamide adenine dinucleotide phosphate-reduced oxidase proteins in Pseudomonas aeruginosa-induced lung inflammation and permeability.
    Fu P; Mohan V; Mansoor S; Tiruppathi C; Sadikot RT; Natarajan V
    Am J Respir Cell Mol Biol; 2013 Apr; 48(4):477-88. PubMed ID: 23306835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease.
    Zhang C; Chen F; Feng L; Shan Q; Zheng GH; Wang YJ; Lu J; Fan SH; Sun CH; Wu DM; Li MQ; Hu B; Wang QQ; Zhang ZF; Zheng YL
    Mol Med; 2019 Jun; 25(1):29. PubMed ID: 31215394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liraglutide Ameliorates Lipotoxicity-Induced Oxidative Stress by Activating the NRF2 Pathway in HepG2 Cells.
    Zhu CG; Luo Y; Wang H; Li JY; Yang J; Liu YX; Qu HQ; Wang BL; Zhu M
    Horm Metab Res; 2020 Jul; 52(7):532-539. PubMed ID: 32375182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRB3 mediates advanced glycation end product-induced apoptosis of pancreatic β-cells through the protein kinase C β pathway.
    Wang M; Zhang W; Xu S; Peng L; Wang Z; Liu H; Fang Q; Deng T; Men X; Lou J
    Int J Mol Med; 2017 Jul; 40(1):130-136. PubMed ID: 28534945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-high-mobility group box-1 (HMGB1) mediates the apoptosis of alveolar epithelial cells (AEC) by receptor of advanced glycation end-products (RAGE)/c-Jun N-terminal kinase (JNK) pathway in the rats of crush injuries.
    Zhang BF; Song W; Wang J; Wen PF; Zhang YM
    J Orthop Surg Res; 2022 Jan; 17(1):20. PubMed ID: 35033142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon Like Peptide-1 Receptor Agonists Alter Pancreatic and Hepatic Histology and Regulation of Endoplasmic Reticulum Stress in High-fat Diet Mouse Model.
    Fang T; Huang S; Chen Y; Chen Z; Chen J; Hu W
    Exp Clin Endocrinol Diabetes; 2021 Sep; 129(9):625-633. PubMed ID: 32961563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Expression of S100B and RAGE in a Mouse Model of Bile Duct Ligation-induced Liver Fibrosis.
    Park JW; Kim MJ; Kim SE; Kim HJ; Jeon YC; Shin HY; Park SJ; Jang MK; Kim DJ; Park CK; Choi EK
    J Korean Med Sci; 2021 Apr; 36(14):e90. PubMed ID: 33847081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.
    Albadrani M; Seth RK; Sarkar S; Kimono D; Mondal A; Bose D; Porter DE; Scott GI; Brooks B; Raychoudhury S; Nagarkatti M; Nagarkatti P; Jule Y; Diehl AM; Chatterjee S
    Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G408-G428. PubMed ID: 31393787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats.
    Xu X; Wang W; Lin L; Chen P
    Tissue Cell; 2020 Oct; 66():101382. PubMed ID: 32933722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
    Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
    Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hesperetin ameliorates hepatic oxidative stress and inflammation
    Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
    Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.